Overview
APMD market data
Price History
APMD price chart · 1M
- O
- 27.83
- H
- 27.83
- L
- 26.73
- C
- 27.22
- Vol
- 7,206.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $27.83
- Previous Close
- $27.96
- Day High
- $27.83
- Day Low
- $26.73
- 52 Week High
- $34.67
- 52 Week Low
- $16.23
- 7 Day Return
- -8.81%
- 30 Day Return
- +3.15%
- 90 Day Return
- +11.06%
- 1 Year Return
- +11.06%
- Daily Notional Volume
- $196.1K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- — Diluted earnings per share over the trailing twelve months.
- Beta
- 3.07 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $16.12 – $35.29 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap —.
Company News
9 captured
LifeSci Capital Initiates Coverage On Apnimed with Outperform Rating, Announces Price Target of $50Benzinga ·
B of A Securities Initiates Coverage On Apnimed with Buy Rating, Announces Price Target of $41Benzinga ·
Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobenewswire Inc ·